Argentum Nitricum in cases of irritate bowel syndrome
Phase 2
- Conditions
- Health Condition 1: K58- Irritable bowel syndrome
- Registration Number
- CTRI/2023/09/057286
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pre diagnosed or with clinical presentation of IBS
will be randomly selected confirmed with Rome
criteria
-All socio economic status
Exclusion Criteria
-Having gross pathological changes
-Suffering from other diseases along with ibs
-Cases with irregular follow ups
-Pregnant and lactating woman
-Severely ill patients who requires immidiate
hospitalization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of Argentum Nitricum in cases of IBSTimepoint: 3 months,6 Months
- Secondary Outcome Measures
Name Time Method To assess the impact of Irritable Bowel Syndrome on individuals using IBS severity scoring systemTimepoint: 3 months,6 Months